Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive imatinib (n=69) or interferon (IFN)/Ara-C (n=70). The response was sequentially monitored by cytogenetics from bone marrow metaphase...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
02 October 2003
|
| In: |
Leukemia
Year: 2003, Jahrgang: 17, Heft: 12, Pages: 2392-2400 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/sj.leu.2403157 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.leu.2403157 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/2403157 
|
| Verfasserangaben: | M. C. Müller, N. Gattermann, T. Lahaye, M. W. N. Deininger, A. Berndt, S. Fruehauf, A. Neubauer, T. Fischer, D. K. Hossfeld, F. Schneller, S. W. Krause, C. Nerl, H. G. Sayer, O. G. Ottmann, C. Waller, W. Aulitzky, P. le Coutre, M. Freund, K. Merx, P. Paschka, H. König, S. Kreil, U. Berger, H. Gschaidmeier, R. Hehlmann and A. Hochhaus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1801712336 | ||
| 003 | DE-627 | ||
| 005 | 20230426073516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220513s2003 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.leu.2403157 |2 doi | |
| 035 | |a (DE-627)1801712336 | ||
| 035 | |a (DE-599)KXP1801712336 | ||
| 035 | |a (OCoLC)1341460011 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Müller, Martin Christian |d 1972- |e VerfasserIn |0 (DE-588)121360296 |0 (DE-627)705409236 |0 (DE-576)181482819 |4 aut | |
| 245 | 1 | 0 | |a Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C |c M. C. Müller, N. Gattermann, T. Lahaye, M. W. N. Deininger, A. Berndt, S. Fruehauf, A. Neubauer, T. Fischer, D. K. Hossfeld, F. Schneller, S. W. Krause, C. Nerl, H. G. Sayer, O. G. Ottmann, C. Waller, W. Aulitzky, P. le Coutre, M. Freund, K. Merx, P. Paschka, H. König, S. Kreil, U. Berger, H. Gschaidmeier, R. Hehlmann and A. Hochhaus |
| 246 | 3 | 3 | |a Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C |
| 264 | 1 | |c 02 October 2003 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.05.2022 | ||
| 520 | |a We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive imatinib (n=69) or interferon (IFN)/Ara-C (n=70). The response was sequentially monitored by cytogenetics from bone marrow metaphases (n=803) and qualitative and quantitative RT-PCR from peripheral blood samples (n=1117). Complete cytogenetic response (CCR) was achieved in 60 (imatinib, 87%) vs 10 patients (IFN/Ara-C, 14%) after a median observation time of 24 months. Within the first year after CCR, best median ratio BCR-ABL/ABL was 0.087%, (imatinib, n=48) vs 0.27% (IFN/Ara-C, n=9, P=0.025). BCR-ABL was undetectable in 25 cases by real-time PCR, but in only four patients by nested PCR. Median best response in patients with relapse after CCR was 0.24% (n=3) as compared to 0.029% in patients with continuous remission (n=52, P=0.029). We conclude that (i) treatment with imatinib in newly diagnosed CML patients is associated with a rapid decrease of BCR-ABL transcript levels; (ii) nested PCR may reveal residual BCR-ABL transcripts in samples that are negative by real-time PCR; (iii) BCR-ABL transcript levels parallel cytogenetic response, and (iv) imatinib is superior to IFN/Ara-C in terms of the speed and degree of molecular responses, but residual disease is rarely eliminated. | ||
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a general | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Intensive / Critical Care Medicine | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Medicine/Public Health | |
| 650 | 4 | |a Oncology | |
| 700 | 1 | |a Gattermann, N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lahaye, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deininger, M. W. N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berndt, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frühauf, Stefan |d 1964- |e VerfasserIn |0 (DE-588)113078676 |0 (DE-627)618240306 |0 (DE-576)317921320 |4 aut | |
| 700 | 1 | |a Neubauer, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fischer, Thomas |d 1958- |e VerfasserIn |0 (DE-588)1257794345 |0 (DE-627)1802480323 |4 aut | |
| 700 | 1 | |a Hossfeld, D. K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneller, F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krause, S. W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nerl, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sayer, H. G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ottmann, O. G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Waller, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aulitzky, W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Coutre, P. le |e VerfasserIn |4 aut | |
| 700 | 1 | |a Freund, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Merx, Kirsten |d 1970- |e VerfasserIn |0 (DE-588)122413091 |0 (DE-627)70589892X |0 (DE-576)293258910 |4 aut | |
| 700 | 1 | |a Paschka, Peter |d 1970- |e VerfasserIn |0 (DE-588)123089840 |0 (DE-627)706156870 |0 (DE-576)293550832 |4 aut | |
| 700 | 1 | |a König, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreil, Sebastian |d 1972- |e VerfasserIn |0 (DE-588)1072240564 |0 (DE-627)827077742 |0 (DE-576)433714093 |4 aut | |
| 700 | 1 | |a Berger, Ute |e VerfasserIn |0 (DE-588)1255399929 |0 (DE-627)1799635341 |4 aut | |
| 700 | 1 | |a Gschaidmeier, Harald |d 1965- |e VerfasserIn |0 (DE-588)172811074 |0 (DE-627)697741354 |0 (DE-576)133667324 |4 aut | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 17(2003), 12, Seite 2392-2400 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C |
| 773 | 1 | 8 | |g volume:17 |g year:2003 |g number:12 |g pages:2392-2400 |g extent:9 |a Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.leu.2403157 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/2403157 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220513 | ||
| 993 | |a Article | ||
| 994 | |a 2003 | ||
| 998 | |g 1107039339 |a Hochhaus, Andreas |m 1107039339:Hochhaus, Andreas |d 60000 |d 61200 |e 60000PH1107039339 |e 61200PH1107039339 |k 0/60000/ |k 1/60000/61200/ |p 26 |y j | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |e 60000PH1037003489 |e 61200PH1037003489 |k 0/60000/ |k 1/60000/61200/ |p 25 | ||
| 998 | |g 1255399929 |a Berger, Ute |m 1255399929:Berger, Ute |d 60000 |d 61200 |e 60000PB1255399929 |e 61200PB1255399929 |k 0/60000/ |k 1/60000/61200/ |p 23 | ||
| 998 | |g 1072240564 |a Kreil, Sebastian |m 1072240564:Kreil, Sebastian |d 60000 |d 61200 |e 60000PK1072240564 |e 61200PK1072240564 |k 0/60000/ |k 1/60000/61200/ |p 22 | ||
| 998 | |g 123089840 |a Paschka, Peter |m 123089840:Paschka, Peter |d 60000 |d 61200 |e 60000PP123089840 |e 61200PP123089840 |k 0/60000/ |k 1/60000/61200/ |p 20 | ||
| 998 | |g 122413091 |a Merx, Kirsten |m 122413091:Merx, Kirsten |d 60000 |d 61200 |e 60000PM122413091 |e 61200PM122413091 |k 0/60000/ |k 1/60000/61200/ |p 19 | ||
| 998 | |g 113078676 |a Frühauf, Stefan |m 113078676:Frühauf, Stefan |d 50000 |e 50000PF113078676 |k 0/50000/ |p 6 | ||
| 998 | |g 121360296 |a Müller, Martin Christian |m 121360296:Müller, Martin Christian |d 60000 |d 61200 |e 60000PM121360296 |e 61200PM121360296 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1801712336 |e 413389216X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Müller","display":"Müller, Martin Christian","given":"Martin Christian","role":"aut"},{"role":"aut","given":"N.","display":"Gattermann, N.","family":"Gattermann"},{"given":"T.","role":"aut","family":"Lahaye","display":"Lahaye, T."},{"display":"Deininger, M. W. N.","family":"Deininger","role":"aut","given":"M. W. N."},{"given":"A.","role":"aut","family":"Berndt","display":"Berndt, A."},{"display":"Frühauf, Stefan","family":"Frühauf","given":"Stefan","role":"aut"},{"family":"Neubauer","display":"Neubauer, A.","given":"A.","role":"aut"},{"given":"Thomas","role":"aut","family":"Fischer","display":"Fischer, Thomas"},{"display":"Hossfeld, D. K.","family":"Hossfeld","role":"aut","given":"D. K."},{"display":"Schneller, F.","family":"Schneller","given":"F.","role":"aut"},{"role":"aut","given":"S. W.","display":"Krause, S. W.","family":"Krause"},{"family":"Nerl","display":"Nerl, C.","given":"C.","role":"aut"},{"given":"H. G.","role":"aut","display":"Sayer, H. G.","family":"Sayer"},{"display":"Ottmann, O. G.","family":"Ottmann","role":"aut","given":"O. G."},{"role":"aut","given":"C.","display":"Waller, C.","family":"Waller"},{"given":"W.","role":"aut","family":"Aulitzky","display":"Aulitzky, W."},{"display":"Coutre, P. le","family":"Coutre","role":"aut","given":"P. le"},{"family":"Freund","display":"Freund, M.","role":"aut","given":"M."},{"role":"aut","given":"Kirsten","family":"Merx","display":"Merx, Kirsten"},{"role":"aut","given":"Peter","display":"Paschka, Peter","family":"Paschka"},{"role":"aut","given":"H.","display":"König, H.","family":"König"},{"given":"Sebastian","role":"aut","family":"Kreil","display":"Kreil, Sebastian"},{"role":"aut","given":"Ute","family":"Berger","display":"Berger, Ute"},{"given":"Harald","role":"aut","display":"Gschaidmeier, Harald","family":"Gschaidmeier"},{"role":"aut","given":"Rüdiger","family":"Hehlmann","display":"Hehlmann, Rüdiger"},{"given":"Andreas","role":"aut","family":"Hochhaus","display":"Hochhaus, Andreas"}],"language":["eng"],"titleAlt":[{"title":"Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C"}],"note":["Gesehen am 13.05.2022"],"origin":[{"dateIssuedDisp":"02 October 2003","dateIssuedKey":"2003"}],"title":[{"title_sort":"Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C","title":"Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"part":{"volume":"17","extent":"9","year":"2003","pages":"2392-2400","text":"17(2003), 12, Seite 2392-2400","issue":"12"},"language":["eng"],"id":{"zdb":["2008023-2"],"issn":["1476-5551"],"eki":["32046699X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"32046699X","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-CLeukemia","title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}],"pubHistory":["Nachgewiesen 11.1997 -"],"note":["Gesehen am 15.03.04"],"origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}]}],"recId":"1801712336","name":{"displayForm":["M. C. Müller, N. Gattermann, T. Lahaye, M. W. N. Deininger, A. Berndt, S. Fruehauf, A. Neubauer, T. Fischer, D. K. Hossfeld, F. Schneller, S. W. Krause, C. Nerl, H. G. Sayer, O. G. Ottmann, C. Waller, W. Aulitzky, P. le Coutre, M. Freund, K. Merx, P. Paschka, H. König, S. Kreil, U. Berger, H. Gschaidmeier, R. Hehlmann and A. Hochhaus"]},"physDesc":[{"extent":"9 S."}],"id":{"eki":["1801712336"],"doi":["10.1038/sj.leu.2403157"]}} | ||
| SRT | |a MUELLERMARDYNAMICSOF0220 | ||